<DOC>
	<DOCNO>NCT00162903</DOCNO>
	<brief_summary>BACKGROUND Patent ductus arteriosus ( PDA ) frequent clinical event preterm infant . The cardiopulmonary function preterm baby may adversely affected patency ductus arteriosus . Ductal tissue sensitive constrict effect endothelin-1 dilating effect prostaglandin , inflammatory mediator , concentration oxygen . OBJECTIVE To examine role endogenous nitric oxide ( NO ) endothelin-1 ( ET-1 ) pathogenesis patent ductus arteriosus preterm infant . We hypothesize patency ductus arterious preterm infant probably due inappropriate production endogenous nitric oxide interaction various inflammatory mediator prostaglandin , different term infant . In addition , secretion endothelin probably decrease . The purpose study monitor change substance sequentially , evaluate relationship among endothelin-1 , endogenous nitric oxide , inflammatory mediator pathophysiology patent ductus arteriosus preterm infant . METHODS AND MATERIALS 1 . Inclusion criterion : 1 . Preterm infant gestational age le 32 week birth weight less 2000 gm . 2 . Informed consent 2 . Numbers study population : With 80-100 evaluable infant ( 40-50 patient PDA non-PDA group , respectively ) 3 . Blood sample , collect day 1,3,7 regular echocardiographic evaluation , assess inflammatory mediator ( IL-8 , IL-10 ) , nitric oxide metabolite ( nitrite nitrate ) , endothelin-1 , cGMP 4 . Statistical analysis : Student t-test testing difference clinical data , Wilcoxon sign rank test comparing data obtain PDA non-PDA patient , PDA patient intravenous indomethacin , responsive refractory therapy .</brief_summary>
	<brief_title>Nitric Oxide , Endothelin-1 , Patency Ductus Arteriosus Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Clinical diagnosis patency ductus arteriosus Congenital anomaly</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>October 2001</verification_date>
	<keyword>Preterm infant , Patent ductus arteriosus , Nitric oxide , Endothelin-1</keyword>
</DOC>